Matinas BioPharma Holdings, Inc. (MTNB)

USD 0.59

(-0.45%)

EBITDA Summary of Matinas BioPharma Holdings, Inc.

  • Matinas BioPharma Holdings, Inc.'s latest annual EBITDA in 2023 was -22.82 Million USD , up 18.72% from previous year.
  • Matinas BioPharma Holdings, Inc.'s latest quarterly EBITDA in 2024 Q2 was -5.59 Million USD , up 1.13% from previous quarter.
  • Matinas BioPharma Holdings, Inc. reported an annual EBITDA of -24.23 Million USD in 2022, down -7.74% from previous year.
  • Matinas BioPharma Holdings, Inc. reported an annual EBITDA of -24.45 Million USD in 2021, down -3.1% from previous year.
  • Matinas BioPharma Holdings, Inc. reported a quarterly EBITDA of -5.59 Million USD for 2024 Q2, up 1.13% from previous quarter.
  • Matinas BioPharma Holdings, Inc. reported a quarterly EBITDA of -5.35 Million USD for 2023 Q1, up 23.59% from previous quarter.

Annual EBITDA Chart of Matinas BioPharma Holdings, Inc. (2023 - 2012)

Historical Annual EBITDA of Matinas BioPharma Holdings, Inc. (2023 - 2012)

Year EBITDA EBITDA Growth
2023 -22.82 Million USD 18.72%
2022 -24.23 Million USD -7.74%
2021 -24.45 Million USD -3.1%
2020 -23.91 Million USD -26.86%
2019 -18.59 Million USD -38.12%
2018 -14.42 Million USD 15.32%
2017 -16.4 Million USD -91.89%
2016 -8.2 Million USD 16.43%
2015 -9.86 Million USD 0.64%
2014 -10.42 Million USD -188.11%
2013 -3.71 Million USD 0.0%
2012 - USD 0.0%

Peer EBITDA Comparison of Matinas BioPharma Holdings, Inc.

Name EBITDA EBITDA Difference
AIM ImmunoTech Inc. -31.67 Million USD 27.947%
Ampio Pharmaceuticals, Inc. - USD Infinity%
Armata Pharmaceuticals, Inc. -39.91 Million USD 42.82%
Actinium Pharmaceuticals, Inc. -51.13 Million USD 55.359%
Azitra, Inc. -10.67 Million USD -113.854%
Can-Fite BioPharma Ltd. -8.18 Million USD -179.034%
Chromocell Therapeutics Corporation -6.86 Million USD -232.615%
Calidi Biotherapeutics, Inc. -28.6 Million USD 20.192%
CEL-SCI Corporation -27.56 Million USD 17.182%
iBio, Inc. -14.02 Million USD -62.792%
Lineage Cell Therapeutics, Inc. -24.73 Million USD 7.714%
MAIA Biotechnology, Inc. -20.18 Million USD -13.094%
Navidea Biopharmaceuticals, Inc. -13.87 Million USD -64.503%
NovaBay Pharmaceuticals, Inc. -4.8 Million USD -375.521%
NanoViricides, Inc. -7.75 Million USD -194.247%
Oragenics, Inc. -20.87 Million USD -9.328%
BiomX Inc. -22.81 Million USD -0.044%
BiomX Inc. -22.81 Million USD -0.044%
Protalix BioTherapeutics, Inc. 11.65 Million USD 295.906%
Palatin Technologies, Inc. -29.03 Million USD 21.378%
Scorpius Holdings, Inc. -35.08 Million USD 34.939%